Home>Topics>Stocks>Eclipsys Corporation

Eclipsys Corporation ECLP

  1. All
  2. Commentary
  3. Stock Reports
    1. Health-Care IT Adoption Benefits Allscripts

      Commentary

      Wed, 21 Jul 2010

      assessment of the future revenue and profitability opportunities resulting from the company's proposed merger with Eclipsys ECLP . For the quarter, revenue of $190 million and bookings of $119 million increased 14% and 15%, respectively, on a year

    2. Prescription to stay in Allscripts-Eclipsys deal …

      Commentary

      Mon, 19 Jul 2010

      were interested to see that the first retention bonuses laid out in merger documents filed by medical-record company Eclipsys ( ECLP ) actually benefit the top officers of Allscripts (MDRX), which is buying Eclipsys for $1.3 billion or so in stock

    3. Changing Eclipsys Valuation to Account for Merger

      Commentary

      Thu, 8 Jul 2010

      Eclipsys ECLP management announced that the company will merge with Allscripts-Misys MDRX in an all-stock transaction. Under the terms of

    4. New Morningstar Analyst Report - Eclipsys Corporation

      Stock Reports

      Thu, 8 Jul 2010

      Health-care IT spending shows signs of life, improving Eclipsys' near-term outlook.

    5. Eclipsys to Merge with Allscripts

      Commentary

      Wed, 9 Jun 2010

      Eclipsys ECLP management announced that the company will merge with Allscripts-Misys MDRX in an all-stock transaction. Under the terms of

    6. Allscripts-Misys to Merge with Eclipsys

      Commentary

      Wed, 9 Jun 2010

      On Wednesday, Allscripts-Misys MDRX and Eclipsys ECLP announced an all-stock merger transaction, making the future combined entity one of the largest providers of health-care IT

    7. Stimulus Standards to Benefit Eclipsys

      Commentary

      Wed, 10 Mar 2010

      Eclipsys' ECLP fourth-quarter results met our expectations, and we are leaving our fair value estimate unchanged. Though the quarter's top

    8. Eclipsys Prepares for Reforms

      Stock Reports

      Wed, 25 Nov 2009

      Eclipsys' ECLP third-quarter earnings met our expectations. We are maintaining our fair value estimate for now, although we might increase

    9. Pending Reforms Boost Eclipsys' Near Term

      Commentary

      Wed, 19 Aug 2009

      We are increasing our fair value estimate for Eclipsys ECLP . The firm posted second-quarter results that slightly exceeded our expectations, and we see signs that the past year's lull

    10. ECLP Management Looks to the HITECH Act

      Commentary

      Mon, 11 May 2009

      Eclipsys ECLP released first-quarter earnings that met our expectations. We are maintaining our fair value estimate. First-quarter revenue

    « Prev12Next »
    Content Partners